Hanseatic Management Services Inc Regeneron Pharmaceuticals, Inc. Transaction History

Hanseatic Management Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $250,629 - $318,581	-524 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$544.75 - $658.21 $1.25 Million - $1.51 Million	-2,288 Reduced 81.37%	524 $293,000
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $260,966 - $340,633	529 Added 23.17%	2,812 $1.75 Million
Q1 2020 Apr 22, 2020	BUY	$336.18 - $494.43 $767,498 - $1.13 Million	2,283 New	2,283 $1.12 Million
Q2 2019 Jul 19, 2019	SELL	$299.6 - $414.82 $423,035 - $585,725	-1,412 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $525,376 - $620,672	1,412 New	1,412 $580,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.